AVIR
Price
$3.50
Change
-$0.03 (-0.85%)
Updated
Jan 15, 11:05 AM (EDT)
Capitalization
276.57M
47 days until earnings call
Intraday BUY SELL Signals
DAWN
Price
$10.99
Change
+$0.26 (+2.42%)
Updated
Jan 15, 11:21 AM (EDT)
Capitalization
1.1B
53 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AVIR vs DAWN

Header iconAVIR vs DAWN Comparison
Open Charts AVIR vs DAWNBanner chart's image
Atea Pharmaceuticals
Price$3.50
Change-$0.03 (-0.85%)
Volume$772
Capitalization276.57M
Day One Biopharmaceuticals
Price$10.99
Change+$0.26 (+2.42%)
Volume$1.4K
Capitalization1.1B
AVIR vs DAWN Comparison Chart in %
AVIR
Daily Signal:
Gain/Loss:
DAWN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AVIR vs. DAWN commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVIR is a Hold and DAWN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (AVIR: $3.54 vs. DAWN: $10.73)
Brand notoriety: AVIR and DAWN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVIR: 53% vs. DAWN: 75%
Market capitalization -- AVIR: $276.57M vs. DAWN: $1.1B
AVIR [@Biotechnology] is valued at $276.57M. DAWN’s [@Biotechnology] market capitalization is $1.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVIR’s FA Score shows that 0 FA rating(s) are green whileDAWN’s FA Score has 0 green FA rating(s).

  • AVIR’s FA Score: 0 green, 5 red.
  • DAWN’s FA Score: 0 green, 5 red.
According to our system of comparison, DAWN is a better buy in the long-term than AVIR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVIR’s TA Score shows that 5 TA indicator(s) are bullish while DAWN’s TA Score has 5 bullish TA indicator(s).

  • AVIR’s TA Score: 5 bullish, 6 bearish.
  • DAWN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, DAWN is a better buy in the short-term than AVIR.

Price Growth

AVIR (@Biotechnology) experienced а +1.72% price change this week, while DAWN (@Biotechnology) price change was +11.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.23%. For the same industry, the average monthly price growth was +2.54%, and the average quarterly price growth was +43.40%.

Reported Earning Dates

AVIR is expected to report earnings on Mar 03, 2026.

DAWN is expected to report earnings on Mar 09, 2026.

Industries' Descriptions

@Biotechnology (-0.23% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DAWN($1.1B) has a higher market cap than AVIR($277M). DAWN YTD gains are higher at: 15.129 vs. AVIR (-0.840). DAWN (-162.07M) and AVIR (-164.56M) have comparable annual earnings (EBITDA) . DAWN has more cash in the bank: 452M vs. AVIR (329M). AVIR has less debt than DAWN: AVIR (1.05M) vs DAWN (2.89M). DAWN has higher revenues than AVIR: DAWN (134M) vs AVIR (0).
AVIRDAWNAVIR / DAWN
Capitalization277M1.1B25%
EBITDA-164.56M-162.07M102%
Gain YTD-0.84015.129-6%
P/E RatioN/AN/A-
Revenue0134M-
Total Cash329M452M73%
Total Debt1.05M2.89M36%
FUNDAMENTALS RATINGS
AVIR: Fundamental Ratings
AVIR
OUTLOOK RATING
1..100
83
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
32

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVIRDAWN
RSI
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 8 days ago
77%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 11 days ago
80%
Bearish Trend 7 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
AVIR
Daily Signal:
Gain/Loss:
DAWN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LIFZF22.980.38
+1.66%
Labrador Iron Ore Royalty Corp.
SMDPY11.45N/A
N/A
Sumitomo Pharma Co Ltd.
PLAOF12.00N/A
N/A
Patria Latin American Opportunity Acquisition Corp.
WMMVF3.24-0.19
-5.54%
Wal-Mart De Mexico S.A.B. de C.V.
ASXSF0.36-0.03
-6.81%
Elysee Development Corp.

AVIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVIR has been loosely correlated with AXON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if AVIR jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVIR
1D Price
Change %
AVIR100%
+0.85%
AXON - AVIR
46%
Loosely correlated
-1.92%
XENE - AVIR
40%
Loosely correlated
+3.02%
KRRO - AVIR
36%
Loosely correlated
+0.11%
DAWN - AVIR
36%
Loosely correlated
+1.32%
VCYT - AVIR
36%
Loosely correlated
-1.39%
More

DAWN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DAWN has been loosely correlated with BEAM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DAWN jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DAWN
1D Price
Change %
DAWN100%
+1.32%
BEAM - DAWN
46%
Loosely correlated
+2.49%
VCYT - DAWN
43%
Loosely correlated
-1.39%
FHTX - DAWN
43%
Loosely correlated
-5.54%
XNCR - DAWN
42%
Loosely correlated
+3.66%
REPL - DAWN
42%
Loosely correlated
-4.10%
More